Literature DB >> 11462172

Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells.

D Wöhrle1, U Salat, H Hameister, W Vogel, P Steinbach.   

Abstract

The major causes of fragile X syndrome are mutational expansion of the CGG repeat in the FMR1 gene, hypermethylation, and transcriptional silencing. Most fragile X embryos develop somatic mosaicism of disease-causing "full" expansions of different lengths. Homogeneity of the mosaic patterns among multiple tissues in the same individual indicates that these previously unstable expansions acquire mitotic stability early in fetal life. Since mitotic stability is found strictly associated with hypermethylation in adult tissues, current theory has fixed the time of instability to developmental stages when fully expanded CGG repeats exist in an unmethylated state. We used murine embryocarcinoma (EC) cells (PC13) as a model system of pluripotent embryonic cells. Hypermethylated and unmethylated full expansions on human fragile X chromosomes were transferred from murine A9 hybrids into EC cells, by means of microcell fusion. As demonstrated in the present study for the first time, even full expansion alleles that were fully methylated and stable in the donors' fibroblasts and in A9 became demethylated, reactivated, and destabilized in undifferentiated EC hybrids. When destabilized expansions were reintroduced from EC cells into A9, instability was reversed to stability. Our results strongly support the idea that fully expanded alleles are initially unstable and unmethylated in the human embryo and gain stability upon genetic or epigenetic change of the embryonic cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11462172      PMCID: PMC1235481          DOI: 10.1086/322739

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  31 in total

1.  Metabolic co-operation in HGPRT+ and HGPRT- embryonal carcinoma cells.

Authors:  M L Hooper; C Slack
Journal:  Dev Biol       Date:  1977-02       Impact factor: 3.582

2.  Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion.

Authors:  D Wöhrle; I Hennig; W Vogel; P Steinbach
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

3.  Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?

Authors:  U Salat; B Bardoni; D Wöhrle; P Steinbach
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

4.  Characterization of the full fragile X syndrome mutation in fetal gametes.

Authors:  H E Malter; J C Iber; R Willemsen; E de Graaff; J C Tarleton; J Leisti; S T Warren; B A Oostra
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

5.  Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development.

Authors:  D Devys; V Biancalana; F Rousseau; J Boué; J L Mandel; I Oberlé
Journal:  Am J Med Genet       Date:  1992 Apr 15-May 1

6.  A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases.

Authors:  F Rousseau; D Heitz; J Tarleton; J MacPherson; H Malmgren; N Dahl; A Barnicoat; C Mathew; E Mornet; I Tejada
Journal:  Am J Hum Genet       Date:  1994-08       Impact factor: 11.025

7.  Fine structure of the human FMR1 gene.

Authors:  E E Eichler; S Richards; R A Gibbs; D L Nelson
Journal:  Hum Mol Genet       Date:  1993-08       Impact factor: 6.150

8.  Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.

Authors:  Y H Fu; D P Kuhl; A Pizzuti; M Pieretti; J S Sutcliffe; S Richards; A J Verkerk; J J Holden; R G Fenwick; S T Warren
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

9.  Heterogeneity of DM kinase repeat expansion in different fetal tissues and further expansion during cell proliferation in vitro: evidence for a casual involvement of methyl-directed DNA mismatch repair in triplet repeat stability.

Authors:  D Wöhrle; I Kennerknecht; M Wolf; H Enders; S Schwemmle; P Steinbach
Journal:  Hum Mol Genet       Date:  1995-07       Impact factor: 6.150

10.  Inheritance of the fragile X syndrome: size of the fragile X premutation is a major determinant of the transition to full mutation.

Authors:  D Heitz; D Devys; G Imbert; C Kretz; J L Mandel
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

View more
  25 in total

Review 1.  Microcell-mediated chromosome transfer (MMCT): small cells with huge potential.

Authors:  Aideen M O Doherty; Elizabeth M C Fisher
Journal:  Mamm Genome       Date:  2003-09       Impact factor: 2.957

2.  CpG methylation modifies the genetic stability of cloned repeat sequences.

Authors:  Kerrie Nichol; Christopher E Pearson
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

Review 3.  The Repeat Expansion Diseases: The dark side of DNA repair.

Authors:  Xiao-Nan Zhao; Karen Usdin
Journal:  DNA Repair (Amst)       Date:  2015-04-30

Review 4.  Repeat instability during DNA repair: Insights from model systems.

Authors:  Karen Usdin; Nealia C M House; Catherine H Freudenreich
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-01-22       Impact factor: 8.250

5.  A Set of Assays for the Comprehensive Analysis of FMR1 Alleles in the Fragile X-Related Disorders.

Authors:  Bruce E Hayward; Yifan Zhou; Daman Kumari; Karen Usdin
Journal:  J Mol Diagn       Date:  2016-08-12       Impact factor: 5.568

Review 6.  Chromatin changes in the development and pathology of the Fragile X-associated disorders and Friedreich ataxia.

Authors:  Daman Kumari; Rachel Lokanga; Dmitry Yudkin; Xiao-Nan Zhao; Karen Usdin
Journal:  Biochim Biophys Acta       Date:  2012-01-05

7.  Gender and cell-type-specific effects of the transcription-coupled repair protein, ERCC6/CSB, on repeat expansion in a mouse model of the fragile X-related disorders.

Authors:  Xiao-Nan Zhao; Karen Usdin
Journal:  Hum Mutat       Date:  2014-03       Impact factor: 4.878

8.  Dimethyl sulfoxide induces chemotherapeutic resistance in the treatment of testicular embryonal carcinomas.

Authors:  Hiroko Kita; Keisei Okamoto; Ryoji Kushima; Akihiro Kawauchi; Tokuhiro Chano
Journal:  Oncol Lett       Date:  2015-06-02       Impact factor: 2.967

9.  A nonsynonymous SNP within PCDH15 is associated with lipid traits in familial combined hyperlipidemia.

Authors:  Adriana Huertas-Vazquez; Christopher L Plaisier; Ruishuang Geng; Blake E Haas; Jenny Lee; Marleen M Greevenbroek; Carla van der Kallen; Tjerk W A de Bruin; Marja-Riitta Taskinen; Kumar N Alagramam; Päivi Pajukanta
Journal:  Hum Genet       Date:  2009-10-09       Impact factor: 4.132

10.  Improved methodology for assessment of mRNA levels in blood of patients with FMR1 related disorders.

Authors:  David E Godler; Danuta Z Loesch; Richard Huggins; Lavinia Gordon; Howard R Slater; Freya Gehling; Trent Burgess; K H Andy Choo
Journal:  BMC Clin Pathol       Date:  2009-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.